首页> 美国卫生研究院文献>OncoTargets and therapy >xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies
【2h】

xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies

机译:xCELLigence系统可实时监测血液恶性肿瘤细胞系的生长和活力而无需使用标签

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The xCELLigence system is a new technological approach that allows the real-time cell analysis of adherent tumor cells. To date, xCELLigence has not been able to monitor the growth or cytotoxicity of nonadherent cells derived from hematological malignancies. The basis of its technology relies on the use of culture plates with gold microelectrodes located in their base. We have adapted the methodology described by others to xCELLigence, based on the pre-coating of the cell culture surface with specific substrates, some of which are known to facilitate cell adhesion in the extracellular matrix. Pre-coating of the culture plates with fibronectin, compared to laminin, collagen, or gelatin, significantly induced the adhesion of most of the leukemia/lymphoma cells assayed (Jurkat, L1236, KMH2, and K562). With a fibronectin substrate, nonadherent cells deposited in a monolayer configuration, and consequently, the cell growth and viability were robustly monitored. We further demonstrate the feasibility of xCELLigence for the real-time monitoring of the cytotoxic properties of several antineoplastic agents. In order to validate this technology, the data obtained through real-time cell analysis was compared with that obtained from using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. This provides an excellent label-free tool for the screening of drug efficacy in nonadherent cells and discriminates optimal time points for further molecular analysis of cellular events associated with treatments, reducing both time and costs.
机译:xCELLigence系统是一种新技术,可对粘附的肿瘤细胞进行实时细胞分析。迄今为止,xCELLigence尚无法监测源自血液恶性肿瘤的非贴壁细胞的生长或细胞毒性。其技术的基础依赖于培养板的使用,培养板的底部装有金微电极。基于细胞培养表面预先涂有特定的底物,我们已经将其他人描述的方法应用于xCELLigence,已知其中一些底物可促进细胞在细胞外基质中的粘附。与层粘连蛋白,胶原蛋白或明胶相比,用纤连蛋白对培养板进行预包被显着诱导了所测定的大多数白血病/淋巴瘤细胞的粘附(Jurkat,L1236,KMH2和K562)。使用纤连蛋白底物,非粘附细胞以单层结构沉积,因此,可以可靠地监测细胞的生长和活力。我们进一步证明了xCELLigence实时监测几种抗肿瘤药的细胞毒性的可行性。为了验证该技术,将通过实时细胞分析获得的数据与使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物方法获得的数据进行了比较。这为筛选非贴壁细胞中的药物功效提供了一个出色的无标记工具,并为进一步对与治疗相关的细胞事件进行分子分析提供了最佳时间点,从而减少了时间和成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号